A dynamic prognostic model to predict survival in post–polycythemia vera myelofibrosis

Author:

Passamonti Francesco1,Rumi Elisa1,Caramella Marianna2,Elena Chiara1,Arcaini Luca1,Boveri Emanuela3,Del Curto Cecilia1,Pietra Daniela1,Vanelli Laura1,Bernasconi Paolo1,Pascutto Cristiana1,Cazzola Mario1,Morra Enrica2,Lazzarino Mario1

Affiliation:

1. Department of Hematology, Fondazione Istituto di ricovero e cura a carattere scientifico (IRCCS) Policlinico San Matteo, University of Pavia, Pavia;

2. Department of Hematology, Ospedale Niguarda Ca' Granda, Milan; and

3. Department of Surgical Pathology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo, University of Pavia, Pavia, Italy

Abstract

Abstract Post–polycythemia vera myelofibrosis (post-PV MF) is a late evolution of PV. In 647 patients with PV, we found that leukocytosis leukocyte count > (15 × 109/L) at diagnosis is a risk factor for the evolution of post-PV MF. In a series of 68 patients who developed post-PV MF, median survival was 5.7 years. Hemoglobin level less than 100 g/L (10 g/dL) at diagnosis of post-PV MF was an independent risk factor for survival. The course of post-PV MF, however, is a dynamic process that implies a progressive worsening of clinical parameters. Using a multivariate Cox proportional hazard regression with time-dependent covariates, we found that a dynamic score based on hemoglobin level less than 100 g/L (10 g/dL), platelet count less than 100 × 109/L, and leukocyte count more than 30 × 109/L is useful to predict survival at any time from diagnosis of post-PV MF. The resulting hazard ratio of the score was 4.2 (95% CI: 2.4-7.7; P < .001), meaning a 4.2-fold worsening of survival for each risk factor acquired during follow up. In conclusion, leukocytosis at diagnosis of PV is a risk factor for evolution in post-PV MF. A dynamic score based on hemoglobin level, and platelet and leukocyte count predicts survival at any time from diagnosis of post-PV MF.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Reference29 articles.

1. Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the international working group for myelofibrosis research and treatment.;Barosi;Leukemia

2. Polycythemia vera: myths, mechanisms, and management.;Spivak;Blood,2002

3. Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia.;Passamonti;Am J Med,2004

4. Polycythemia vera in young patients: a study on the long-term risk of thrombosis, myelofibrosis and leukemia.;Passamonti;Haematologica,2003

5. The JAK2(V617F) tyrosine kinase mutation in myelofibrosis with myeloid metaplasia: lineage specificity and clinical correlates.;Tefferi;Br J Haematol,2005

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3